Informazioni generali
  • Categoria della malattia Cancro del colon-retto , Altro cancro (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Winterthur
    (BASEC)
  • Responsabile dello studio PD Dr. Dr. med. Lukasz Filip Grochola lukaszfilip.grochola@ksw.ch (BASEC)
  • Fonte dati BASEC: Importato da 08.01.2025 ICTRP: N/A
  • Ultimo aggiornamento 08.01.2025 16:08
HumRes66119 | SNCTP000006186 | BASEC2024-D0088

What effects does radiofrequency have in liver surgeries? Can it help prevent cancer recurrence?

  • Categoria della malattia Cancro del colon-retto , Altro cancro (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Winterthur
    (BASEC)
  • Responsabile dello studio PD Dr. Dr. med. Lukasz Filip Grochola lukaszfilip.grochola@ksw.ch (BASEC)
  • Fonte dati BASEC: Importato da 08.01.2025 ICTRP: N/A
  • Ultimo aggiornamento 08.01.2025 16:08

Descrizione riassuntiva dello studio

Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer-related death. Furthermore, the liver is also the primary site for metastases from colorectal cancer, which is the third most common malignant disease worldwide. The standard treatment for liver cancer and liver metastases from colorectal cancer is the surgical removal of the tumor-bearing part of the liver. However, after such surgeries, cancer often recurs. Further research is needed to find a solution to this problem. It may help to treat the tumor margins after surgery with a radiofrequency device to reduce the number of tumor recurrences. This method applies high-frequency electromagnetic waves to the tissue at the tumor margins. The device heats the tissue and thereby kills cancer cells that may have remained after surgery. In the study, participants are randomly assigned to two groups. In the experimental group, liver cell cancer or liver metastases are surgically removed and the tumor margins are additionally cauterized using radiofrequency. In the control group, the cancer is only surgically removed. No additional treatment of the tumor margins is performed. Only the study staff will know which group the participants were assigned to. The aim of the study is to determine whether the additional cauterization of the tumor margins with a radiofrequency device can reduce the local recurrence rate of this cancer.

(BASEC)

Intervento studiato

Surgical removal of liver cell cancer or liver metastases from colon cancer. In the experimental group, the tumor margins are also cauterized using radiofrequency, while in the control group no further treatment of the tumor margins is performed.

(BASEC)

Malattie studiate

Liver cell cancer or liver metastases caused by colon or rectal cancer

(BASEC)

Criteri di partecipazione
1. Written consent after detailed information about the study 2. 18 years or older 3. WHO Performance Status: 0-2 4. Continuous inclusion of patients (evenly distributed between both sexes) with liver metastases from colorectal cancer or patients with liver cell tumors. 5. Previous chemotherapies are allowed 6. ASA (American Society of Anesthesiology Classification) classification of the patient: 1-3 (BASEC)

Criteri di esclusione
1. Previous or concurrent cancers that are not the primary tumor of the liver metastases, except for early-stage cervical cancer, treated skin cancer, or superficial bladder tumors. Cancers successfully treated more than 3 years ago are allowed. 2. ASA (American Society of Anesthesiology Classification) classification of the patient: 4 3. Unresectable metastases outside the liver 4. Liver metastases not originating from colorectal cancer 5. The primary liver tumor must not be benign (BASEC)

Luogo dello studio

Winterthur

(BASEC)

non disponibile

Sponsor

non disponibile

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

PD Dr. Dr. med. Lukasz Filip Grochola

+41522664162

lukaszfilip.grochola@ksw.ch

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione etica Zurigo

(BASEC)

Data di approvazione del comitato etico

22.11.2024

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
non disponibile

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile


Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile